City
Epaper

Nobel laureate Prof Semenza receives Genome Valley Excellence Award

By IANS | Updated: February 27, 2024 13:05 IST

Hyderabad, Feb 27 The Genome Valley Excellence Award for 2024 was conferred on Nobel Prize-winning pediatrician Prof Gregg ...

Open in App

Hyderabad, Feb 27 The Genome Valley Excellence Award for 2024 was conferred on Nobel Prize-winning pediatrician Prof Gregg L. Semenza.

The award was presented to him by Telangana Chief Minister A. Revanth Reddy at the 21st edition of BioAsia, the marquee healthcare and life sciences event of the Government of Telangana which began here on Tuesday.

Prof Semenza was selected for the honour in recognition of his prominent ground-breaking discovery in unveiling the hypoxia-inducible factor 1 (HIF-1 protein), a pivotal discovery controlling gene expression in response to fluctuations in oxygen availability.

Prof Semenza is currently the C. Michael Armstrong Professor of Genetic Medicine at Johns Hopkins University School of Medicine, USA. His pioneering work in the field is critical in the treatment of diseases such as cancer, anemia, blinding eye diseases, and cardiovascular disorders.

He thanked the International Advisory Board of BioAsia consisting of personalities of national and international reputation.

“Throughout my career, I have endeavoured to increase our understanding of fundamental biological processes with the hope of translating that knowledge to the clinic in the form of novel therapies for common diseases. It has been gratifying that our basic science discoveries have been able to develop new effective treatments for anemia and kidney cancer,” he said.

He said that the current research in my laboratories focus on development of novel inhibitors of hypoxia inducible factors for two applications; the prevention of vision loss in patients with diabetic eye disease and macular degeneration and also the treatment of a wide range of human cancers.

“In both of these areas we have very encouraging results from animal studies and are hopeful that these drugs will progress to clinical trials in the near future,” he added.

Prof Semenza had discovered how cells can sense and adapt to changing oxygen availability. During the 1990s, he identified molecular machinery that regulates the activity of genes in response to varying levels of oxygen.

The discoveries may lead to new treatments of anemia, cancer, and many other diseases. He received the eminent Nobel Prize in Physiology or Medicine in the year 2019 for the discovery on “how cells sense and adapt to oxygen availability”.

--IANS

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalTop brass of Pak Army, police offer prayers at LeT terrorists' 'funeral' slain in Op Sindoor

InternationalEarthquake of magnitude 5.7 rocks Tibet

InternationalUkraine President agrees meeting with Putin this week

InternationalUS announces trade deal with China in Geneva

MaharashtraMumbai News: Cops Arrest Trio for Opening Fake Bank Accounts Under ‘Ladki Bahin’ Scheme for Cyber Fraud

Health Realted Stories

HealthGlobal HIV market to cross $32 billion in 7 major markets in 2033: Report

HealthWeekly yoga podcast launched to promote holistic wellness

HealthStudy finds how obesity linked to long Covid

HealthAyushman Bharat turns lifesaver, Uttarakhand woman shares her story of treatment

HealthEarly-life growth proved important for height in puberty, adulthood